Amphastar Pharma (AMPH) Tops Q1 EPS by 26c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $1.04, $0.26 better than the analyst estimate of $0.78. Revenue for the quarter came in at $171.8 million versus the consensus estimate of $176.36 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Diamondrock Hospitality (DRH) PT Raised to $13.50 at Stifel
• Casey's General Stores (CASY) PT Lowered to $720 at UBS on Peak Fuel Margin Concerns